Portrait of Teresa De Marco
ucsf logo

Teresa De Marco, MD

Cardiology • Heart Failure and Transplantation CardiologyMedical Director, Heart Transplantation
Pulmonary Hypertension Parnassus
415-353-2873
Portrait of Teresa De Marco
Portrait of Teresa De Marco
ucsf logo

Teresa De Marco, MD

Cardiology • Heart Failure and Transplantation CardiologyMedical Director, Heart Transplantation
Pulmonary Hypertension Parnassus
415-353-2873

On this page

About me

Dr. Teresa De Marco is medical director of heart transplantation at UCSF. She cares for patients who have advanced heart failure, undergo heart transplants, and need mechanical circulatory support. She also cares for patients with pulmonary hypertension. She has expertise in all methods of treating and managing advanced heart failure and pulmonary hypertension.

In her research, De Marco evaluates state-of-the-art options for patients with advanced heart failure and pulmonary hypertension. She has served as principal investigator in more than 45 clinical trials (studies using human volunteers to assess promising therapies).

After earning her undergraduate degree from the University of California, Berkeley, De Marco earned her medical degree at the University of California, Irvine. She completed a residency in internal medicine at UCSF, followed by fellowship training in heart failure and cardiovascular disease at UCSF and in heart transplantation at the University of Utah.

De Marco received the UCSF Exceptional Physician Award in 2014 and was inducted into the UCSF Council of Master Clinicians in 2018. She has served on the International Society for Heart and Lung Transplantation's board of directors. She is a member of the scientific leadership council of the Pulmonary Hypertension Association (PHA) and the oversight committee of PHA's accreditation program for Pulmonary Hypertension Care Centers. She also serves on the executive committee for Women in Advanced Heart Failure, Transplantation and Mechanical Circulatory Support Interdisciplinary Network Community. She holds the UCSF R.H. and Jane G. Logan Endowed Chair in Cardiology. She is a fellow of the American College of Cardiology and a fellow of the Heart Failure Society of America.

Education & training

Board certification

  • Advanced Heart Failure & Trans, American Board of Internal Medicine
  • Cardiovascular Disease, American Board of Internal Med/Cardiovascular Dis
  • Internal Medicine, American Board of Internal Medicine

Fellowship

  • Clinical Cardiology, UCSF Graduate Medical Education
  • Cardiology, Heart Failure, UCSF Graduate Medical Education

Residency

  • Internal Medicine, UCSF Graduate Medical Education

Internship

  • Internal Medicine, UCSF Graduate Medical Education

Degree

  • MD, University of California Irvine College of Medicine

Locations

    Reviews

    Average rating

    4.8
    4.8 out of 5 Stars
    69 ratings
    About provider reviews

    Showing 1-6 of 7 reviews

    Sort by
    • 5 out of 5 Stars
      November 4, 2025

      Dr. D. Is the best, she is my HERO!

    • 5 out of 5 Stars
      September 30, 2025

      Dr. De Marco is excellent. She explains and goes over everything without rushing. She offers excellent treatment advice and listens to my needs.

    • 4.9 out of 5 Stars
      June 25, 2025

      She's very caring

    • 5 out of 5 Stars
      July 11, 2024

      Dr. De Marco is the reason I switched my cardiology care to UCSF.

    • 5 out of 5 Stars
      June 26, 2024

      Very knowledgeable and courteous

    • 5 out of 5 Stars
      June 15, 2024

      Becky and all the nurses are very responsive to all my questions and always get the information I request

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.